CN112891465A - Medicinal and edible traditional Chinese medicine composition and application thereof - Google Patents
Medicinal and edible traditional Chinese medicine composition and application thereof Download PDFInfo
- Publication number
- CN112891465A CN112891465A CN202110235673.5A CN202110235673A CN112891465A CN 112891465 A CN112891465 A CN 112891465A CN 202110235673 A CN202110235673 A CN 202110235673A CN 112891465 A CN112891465 A CN 112891465A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- tea
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the technical field of health-care products, and particularly relates to a traditional Chinese medicine composition with homology of medicine and food and application thereof. The traditional Chinese medicine composition with homology of medicine and food comprises: 0.1-50 parts of ganoderma lucidum spore powder, 5-50 parts of tremella, 1-100 parts of apocynum venetum, 1-100 parts of comfrey, 1-100 parts of achyranthes bidentata, 3-300 parts of eucommia ulmoides, 1-100 parts of wild chrysanthemum flower, 1-100 parts of ginkgo leaf, 1-100 parts of gastrodia elata and 1-100 parts of plantain seed. According to the invention, the traditional Chinese medicine components with homology of medicine and food are scientifically combined together according to the traditional Chinese medicine dialectical compatibility theory, and the traditional Chinese medicine composition has the effects of nourishing yin, reducing blood pressure, nourishing viscera, clearing head and nourishing brain. The composition of the invention is prepared into the blood pressure reducing tea, has good regulating effect on hypertension, and the total effective rate can reach 100 percent.
Description
Technical Field
The invention relates to the technical field of health-care products, in particular to a traditional Chinese medicine composition with homology of medicine and food and application thereof.
Background
According to related departments, the prevalence rate of adult hypertension in China is counted to be 18.8 percent and is in a trend of rising year by year. At present, the Chinese medicine for treating hypertension has the side effects of causing headache, insomnia and the like. The prior art lacks a product which has small side effect, high effective rate and convenient use and can regulate the hypertension.
Disclosure of Invention
The invention aims to provide a medicine-food homologous traditional Chinese medicine composition and application thereof, the medicine-food homologous traditional Chinese medicine composition has no side effect, has good regulation effect on hypertension, has certain adjuvant therapy effect on relieving symptoms and regulating blood pressure, and also has the effects of reducing blood pressure and preventing cardiovascular and cerebrovascular diseases.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a medicine-food homologous traditional Chinese medicine composition which comprises the following components in parts by mass: 0.1-50 parts of ganoderma lucidum spore powder, 5-50 parts of tremella, 1-100 parts of apocynum venetum, 1-100 parts of comfrey, 1-100 parts of achyranthes bidentata, 3-300 parts of eucommia ulmoides, 1-100 parts of wild chrysanthemum flower, 1-100 parts of ginkgo leaf, 1-100 parts of gastrodia elata and 1-100 parts of plantain seed.
Preferably, the composition comprises the following components in parts by mass: 10-40 parts of ganoderma lucidum spore powder, 15-40 parts of tremella, 20-80 parts of apocynum venetum, 20-80 parts of comfrey, 1-100 parts of achyranthes bidentata, 53-250 parts of eucommia ulmoides, 20-80 parts of wild chrysanthemum flower, 20-80 parts of ginkgo leaf, 20-80 parts of gastrodia elata and 20-80 parts of plantain seed.
Preferably, the composition comprises the following components in parts by mass: 20-30 parts of ganoderma lucidum spore powder, 20-35 parts of tremella, 40-60 parts of apocynum venetum, 40-60 parts of summer mushroom grass, 40-60 parts of achyranthes bidentata, 103-200 parts of eucommia ulmoides, 40-60 parts of wild chrysanthemum flower, 40-60 parts of ginkgo leaf, 40-60 parts of gastrodia elata and 40-60 parts of plantain seed.
Preferably, the composition comprises the following components in parts by mass: 25 parts of ganoderma lucidum spore powder, 27.5 parts of tremella, 50 parts of apocynum venetum, 50 parts of summer mushroom grass, 50 parts of achyranthes root, 151.5 parts of eucommia bark, 50 parts of wild chrysanthemum flower, 50 parts of ginkgo leaf, 50 parts of gastrodia tuber and 50 parts of plantain seed.
The invention also provides application of the composition in preparing a pressure-reducing product.
Preferably, the blood pressure lowering product is blood pressure lowering tea.
Preferably, the antihypertensive tea is brewed with boiled water and then drunk.
Preferably, the blood pressure reducing tea is drunk along with meals.
Preferably, the antihypertensive tea is drunk before meal
Preferably, the dosage of the blood pressure reducing tea is 1-3 times per day, and each time is 5-8 g.
The medicinal and edible traditional Chinese medicine composition is obtained by scientific proportioning, and all the components are combined for use, so that the medicinal and edible traditional Chinese medicine composition has the effects of nourishing yin and lowering blood pressure, nourishing viscera, clearing head and nourishing brain, and preventing cardiovascular and cerebrovascular diseases. And the antihypertensive tea product is prepared from the antihypertensive tea, is convenient to use and has no toxic or side effect.
Detailed Description
In the invention, the blood pressure reducing tea is a product put in a paper bag.
In the invention, each component in the blood pressure reducing tea product is in a powder shape.
The technical solutions provided by the present invention are described in detail below with reference to examples, but they should not be construed as limiting the scope of the present invention.
Example 1
Mixing Tremella 5g, herba Apocyni Veneti 10g, Prunellae Spica 100g, Achyranthis radix 5g, Eucommiae cortex 30g, flos Chrysanthemi Indici 1g, folium Ginkgo 10g, rhizoma Gastrodiae 50g, and semen plantaginis 90g, and pulverizing into powder. Filling the mixture into paper bags according to the amount of 5g per bag to obtain a semi-finished product 1. Then filling the ganoderma lucidum spore powder into paper bags according to the amount of 1g per bag to obtain a semi-finished product 2. And packaging the semi-finished products 1 and 2 to obtain the antihypertensive tea product of the example 1.
Example 2
Mixing Tremella 25g, herba Apocyni Veneti 80g, Prunellae Spica 10g, Achyranthis radix 30g, Eucommiae cortex 200g, flos Chrysanthemi Indici 50g, folium Ginkgo 20g, rhizoma Gastrodiae 10g, and semen plantaginis 10g, and pulverizing into powder. Filling the mixture into paper bags according to the amount of 6g per bag to obtain a semi-finished product 1. Then filling the ganoderma lucidum spore powder into paper bags according to the amount of 2g per bag to obtain a semi-finished product 2. And packaging the semi-finished products 1 and 2. The blood pressure lowering tea product of example 2 was obtained.
Experimental example 1
The semi-finished product 1 in the blood pressure reducing tea product of the embodiment 1 is opened and soaked in boiled water, when the water temperature is reduced to 35 ℃, the paper bag of the semi-finished product 2 of the embodiment 1 is opened, and the ganoderma lucidum spore powder is poured into the paper bag for drinking. It is taken with meal 3 times per day. The antihypertensive tea prepared in example 1 is applied to 29 patients with hypertension according to the method, and the follow-up visit is carried out after 7 days, so that 27 effective cases are found, wherein 15 effective cases are shown, the total effective rate can reach 98.96%, and no adverse reaction is caused.
Experimental example 2
The semi-finished product 1 in the blood pressure reducing tea product of the embodiment 2 is opened and soaked in boiled water, when the water temperature is reduced to 33 ℃, the semi-finished product 2 of the embodiment 2 is opened, and the ganoderma lucidum spore powder is poured into the bag for drinking. It is administered 2 times per day before breakfast and supper. The blood pressure lowering tea of example 2 was used in 30 patients with hypertension according to this method. After 7 days, follow-up visits show that 30 cases of the traditional Chinese medicine are effective, 18 cases of the traditional Chinese medicine are effective, the total effective rate reaches 100%, and no adverse reaction exists.
From the above embodiments, the invention provides a medicinal and edible traditional Chinese medicine composition and an application thereof. According to the experimental examples, the antihypertensive tea prepared from the medicinal and edible traditional Chinese medicine composition can enable the total effective rate of hypertension patients to reach 100%, and has no adverse reaction.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (10)
1. A medicine-food homologous traditional Chinese medicine composition is characterized by comprising the following components in parts by mass: 0.1-50 parts of ganoderma lucidum spore powder, 5-50 parts of tremella, 1-100 parts of apocynum venetum, 1-100 parts of comfrey, 1-100 parts of achyranthes bidentata, 3-300 parts of eucommia ulmoides, 1-100 parts of wild chrysanthemum flower, 1-100 parts of ginkgo leaf, 1-100 parts of gastrodia elata and 1-100 parts of plantain seed.
2. The composition according to claim 1, characterized by comprising the following components in parts by mass: 10-40 parts of ganoderma lucidum spore powder, 15-40 parts of tremella, 20-80 parts of apocynum venetum, 20-80 parts of comfrey, 1-100 parts of achyranthes bidentata, 53-250 parts of eucommia ulmoides, 20-80 parts of wild chrysanthemum flower, 20-80 parts of ginkgo leaf, 20-80 parts of gastrodia elata and 20-80 parts of plantain seed.
3. The composition according to claim 2, characterized by comprising the following components in parts by mass: 20-30 parts of ganoderma lucidum spore powder, 20-35 parts of tremella, 40-60 parts of apocynum venetum, 40-60 parts of summer mushroom grass, 40-60 parts of achyranthes bidentata, 103-200 parts of eucommia ulmoides, 40-60 parts of wild chrysanthemum flower, 40-60 parts of ginkgo leaf, 40-60 parts of gastrodia elata and 40-60 parts of plantain seed.
4. The composition as claimed in any one of claims 1 to 3, which is characterized by comprising the following components in parts by mass: 25 parts of ganoderma lucidum spore powder, 27.5 parts of tremella, 50 parts of apocynum venetum, 50 parts of summer mushroom grass, 50 parts of achyranthes root, 151.5 parts of eucommia bark, 50 parts of wild chrysanthemum flower, 50 parts of ginkgo leaf, 50 parts of gastrodia tuber and 50 parts of plantain seed.
5. Use of a composition according to any one of claims 1 to 4 for the preparation of a reduced pressure product.
6. Use according to claim 5, wherein the hypotensive product is hypotensive tea.
7. The use of claim 6, wherein the tea for lowering blood pressure is brewed with boiled water and then drunk.
8. The use of claim 7, wherein the hypotensive tea is drunk with meals.
9. The use according to claim 8, wherein the hypotensive tea is drunk before meal.
10. The use according to any one of claims 5 to 9, wherein the amount of the blood pressure lowering tea is 1 to 3 times per day, 5 to 8g each time.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110235673.5A CN112891465A (en) | 2021-03-03 | 2021-03-03 | Medicinal and edible traditional Chinese medicine composition and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110235673.5A CN112891465A (en) | 2021-03-03 | 2021-03-03 | Medicinal and edible traditional Chinese medicine composition and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112891465A true CN112891465A (en) | 2021-06-04 |
Family
ID=76108234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110235673.5A Pending CN112891465A (en) | 2021-03-03 | 2021-03-03 | Medicinal and edible traditional Chinese medicine composition and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112891465A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101125164A (en) * | 2007-08-07 | 2008-02-20 | 江西本草天工科技有限责任公司 | Blood-pressure-lowering and blood-lipid-lowering compound apocynum leaf solid preparation and preparation method thereof |
CN101401601A (en) * | 2006-10-18 | 2009-04-08 | 吴建生 | Five-leaf tea for reducing blood pressure, blood fat and blood sugar |
CN104013835A (en) * | 2014-06-25 | 2014-09-03 | 山东省立医院 | Traditional Chinese medicine for treating high blood pressure |
CN104800608A (en) * | 2015-05-06 | 2015-07-29 | 天津怡昇园科技发展有限公司 | Traditional Chinese herbal medicine composition with hypotensive effect and application thereof |
-
2021
- 2021-03-03 CN CN202110235673.5A patent/CN112891465A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101401601A (en) * | 2006-10-18 | 2009-04-08 | 吴建生 | Five-leaf tea for reducing blood pressure, blood fat and blood sugar |
CN101125164A (en) * | 2007-08-07 | 2008-02-20 | 江西本草天工科技有限责任公司 | Blood-pressure-lowering and blood-lipid-lowering compound apocynum leaf solid preparation and preparation method thereof |
CN104013835A (en) * | 2014-06-25 | 2014-09-03 | 山东省立医院 | Traditional Chinese medicine for treating high blood pressure |
CN104800608A (en) * | 2015-05-06 | 2015-07-29 | 天津怡昇园科技发展有限公司 | Traditional Chinese herbal medicine composition with hypotensive effect and application thereof |
Non-Patent Citations (2)
Title |
---|
朱喜英,等: "益肾平肝方对高血压早期肾损害患者动态血压、肾功能及血管内皮功能的影响", 《中成药》 * |
李平,等: "复方罗布麻片对老年高血压患者动态血压的影响", 《中国老年学杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103749816B (en) | Lotus leaf bitter gourd lipid-lowering health-care tea and preparation method thereof | |
CN103583757B (en) | Preparation method of refreshing health tea | |
WO2017201877A1 (en) | Red yeast grape wine and manufacturing method thereof | |
CN102429064B (en) | Compound pin leaf and ganoderma tea and making method thereof | |
CN103749856A (en) | Fiveleaf gynostemma herb health-care tea | |
CN112891465A (en) | Medicinal and edible traditional Chinese medicine composition and application thereof | |
Shiradhonkar et al. | Fortification of wine with herbal extracts: production, evaluation and therapeutic applications of such fortified wines | |
CN104543250A (en) | Cyclocarya paliurus-chrysanthemum tea and preparation method thereof | |
CN105146662B (en) | Three leaf raspberry plant composite beverages and preparation method thereof | |
CN107372967A (en) | A kind of tea-drinking for improving blood stasis constitution | |
KR101058422B1 (en) | Herbal dietary supplement and its manufacturing method | |
CN103828958A (en) | Novel weight-reducing tea and preparation method thereof | |
CN112156140A (en) | Composition for tonifying qi, enriching blood, strengthening spleen and nourishing heart and application thereof | |
CN104971230A (en) | Composition for boosting immunity | |
CN105831335A (en) | A vine tea bag and a preparing method thereof | |
CN104473072A (en) | Punica granatum-flavored zingiber officinale roscoe crystal particles and preparation method thereof | |
KR20070100067A (en) | Method for preparing functional beverage | |
CN109349470A (en) | A kind of rose and preparation method thereof | |
CN104585469A (en) | Chewing gum having protective effect on alcoholic liver injury and preparation method of chewing gum | |
CN104013696A (en) | Plant medicine composition for preventing and treating metabolic syndrome and application thereof | |
CN108419974A (en) | A kind of liver-protecting and alcoholism-relieving beverage and preparation method thereof | |
KR20190041776A (en) | Health tea composition and health tea using medicinal herbs | |
CN107441354A (en) | Application of the Chinese medicine composition in reducing blood lipid or anti-trioxypurine medicine and health products are prepared | |
CN106333191A (en) | Rosa roxburghii tratt fruit vinegar healthcare beverage and preparation method thereof | |
CN107397019B (en) | Health care mango peel composite tea bag and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210604 |